Shares of Anpario plc (LON:ANP – Get Free Report) crossed below its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of GBX 516.89 and traded as low as GBX 506. Anpario shares last traded at GBX 516.17, with a volume of 10,826 shares trading hands.
Analysts Set New Price Targets
Several brokerages recently weighed in on ANP. Canaccord Genuity Group upped their target price on shares of Anpario from GBX 570 to GBX 600 and gave the stock a “buy” rating in a research note on Friday, September 11th. Shore Capital Group reissued a “house stock” rating on shares of Anpario in a research report on Monday, August 17th. One equities research analyst has rated the stock with a Buy rating. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of GBX 600.
Read Our Latest Research Report on Anpario
Anpario Stock Performance
The company has a debt-to-equity ratio of 0.60, a current ratio of 6.29 and a quick ratio of 5.16. The company has a market capitalization of £83.99 million, a price-to-earnings ratio of 13.10 and a beta of 1.05. The stock has a 50 day simple moving average of GBX 506.33 and a two-hundred day simple moving average of GBX 516.89.
Anpario (LON:ANP – Get Free Report) last announced its quarterly earnings results on Wednesday, September 9th. The company reported GBX 22.45 earnings per share (EPS) for the quarter. Anpario had a return on equity of 17.05% and a net margin of 14.53%. As a group, analysts anticipate that Anpario plc will post 23.58 earnings per share for the current year.
About Anpario
Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.
Further Reading
- Five stocks we like better than Anpario
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.
